STOCKHOLDERS??? EQUITY (Details Narrative)

v3.26.1

STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)																													1 Months Ended	12 Months Ended
	Dec. 22, 2025	Dec. 13, 2025	Nov. 05, 2025	Nov. 01, 2025	Oct. 16, 2025	Oct. 01, 2025	Sep. 29, 2025	Sep. 18, 2025	Jun. 17, 2025	Jun. 03, 2025	May 08, 2025	Apr. 25, 2025	Mar. 28, 2025	Mar. 03, 2025	Feb. 24, 2025	Dec. 13, 2024	Nov. 01, 2024	Oct. 01, 2024	Apr. 25, 2024	Mar. 28, 2024	Mar. 14, 2024	Nov. 17, 2023	Nov. 15, 2023	Nov. 13, 2023	Nov. 09, 2023	May 25, 2023	Aug. 03, 2022	Aug. 01, 2022	May 31, 2024	Dec. 31, 2025	Feb. 24, 2025	Dec. 31, 2024	Sep. 28, 2025	Mar. 22, 2025	Dec. 23, 2024	May 15, 2024	Mar. 25, 2024	Feb. 14, 2024	Dec. 31, 2023	Dec. 31, 2022
Subsidiary, Sale of Stock [Line Items]
Proceeds from sale of common stock																														$ 327,615		$ 658,801
Warrants and rights expiration date																		Apr. 24, 2028										Jul. 27, 2027
Research and Development Expense																														453,745
Warrant exercise price per share							$ 1.30	$ 1.30	$ 1.50									$ 2.81										$ 6.25					$ 1.87
Warrants and rights exercisable period																		Oct. 24, 2023										Jan. 23, 2023
Warrant liability																														$ 1,492,395		2,690,605
Fair value assumptions, contractual term																														7 years
Fair value of warrant							$ 124,127	$ 60,275	$ 105,154																					$ (1,198,210)		$ 6,682,758
Issuance of common stock																														13,086,220		6,718,176							3,650,278
Proceeds from warrant exercise																														$ 901,578
Class of warrants weighted average exercise price																														$ 1.58		$ 1.87
Warrants vested shares																														9,702,689		5,442,246
Stock options outstanding																														12,878,381		9,769,992
Percentage of shares granted																														10.00%
Exercise price percentage																														110.00%
2021 Equity Incentive Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Stock options outstanding																														7,600,880
Common stock reserved for issuance																												1,909,518		431,153		2,250,000							2,838,668	1,956,993
Percentage of increase in stock outstanding fully diluted																										10.00%
2018 Stock Option Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Stock options outstanding																														1,773,912
Amended And Restated 2020 Equity Incentive Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Stock options outstanding																														3,503.589
Common stock reserved for issuance																														0
Board of Directors Chairman [Member] | 2021 Equity Incentive Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock reserved for issuance																														6,458,889
Alumni Capital Lp [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants and rights expiration date																									Nov. 10, 2027
Warrant exercise price per share																									$ 2.09
Warrants and rights exercisable period																									Nov. 10, 2023
Fair value assumptions, contractual term																									3 years 10 months 13 days
Risk free interest rate																									3.93%
Volatility rate																									90.00%
Warrants																									$ 84,251
Warrant shares vested																								131,578
Black Sholes Method [Member]
Subsidiary, Sale of Stock [Line Items]
Warrant liability																											$ 343,735
Fair value assumptions, contractual term																		5 years									5 years
Risk free interest rate																		4.09%									2.82%
Volatility rate																		86.30%									77.50%
Warrants																		$ 241,109
Restricted Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Stock compensation expense																														$ 165,070		$ 179,490
Shares granted																														114,767		75,550
Unvested shares																														0		0
Restricted shares of Common Stock																														392,056
Share-Based Payment Arrangement, Option [Member]
Subsidiary, Sale of Stock [Line Items]
Weighted-average grant date fair value																														$ 1.73		$ 2.41
Unrecognized compensation																														$ 3,507,096
Unrecognized compensation expense, recognized period																														2 years 4 months 6 days
Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Number of common stock sold																														3,782,335		3,274,360
Restricted shares of Common Stock																														506,823		75,550
Issuance of common stock								440,503	219,283
Proceeds from warrant exercise								$ 572,654	$ 328,924
Common Stock [Member] | Director [Member] | 2021 Equity Incentive Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Number of common stock sold	179,737					19,230				33,333	86,666
Common Stock [Member] | Non Affiliated Investors [Member]
Subsidiary, Sale of Stock [Line Items]
Number of common stock sold					11,475
Maximum [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase aggregate of common stock																		127,775										100,000
Fair value assumptions, contractual term																														10 years
Maximum [Member] | Board of Directors Chairman [Member] | 2021 Equity Incentive Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock reserved for issuance																														6,890,042
Maximum [Member] | Alumni Capital Lp [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase aggregate of common stock																									239,234
Maximum [Member] | Share-Based Payment Arrangement, Option [Member]
Subsidiary, Sale of Stock [Line Items]
Fair value assumptions, contractual term																														6 years 1 month 6 days		6 years 3 months
Private Placement [Member]
Subsidiary, Sale of Stock [Line Items]
Sale of common stock, price per share	$ 1.224				$ 1.22	$ 1.30				$ 1.50	$ 1.50			$ 1.50	$ 1.50	$ 1.872	$ 2.259		$ 2.034	$ 2.295	$ 1.17										$ 1.50
Aggregate purchase price	$ 1,500,000				$ 700,000	$ 2,300,000				$ 700,000	$ 1,080,000.00			$ 1,400,000	$ 2,700,000	$ 950,000	$ 2,440,000		$ 1,000,000.0	$ 1,330,000	$ 2,920,000
Warrants and rights expiration date															Feb. 24, 2031					Sep. 28, 2029	Sep. 14, 2029										Feb. 24, 2031
Warrant exercise price per share																					$ 1.30
Warrants and rights exercisable period																					Sep. 14, 2024
Fair value of warrant																													$ 769,671	$ 0		$ 3,039,463
Warrants																													5,089,063
Private Placement [Member] | Amendment Of Warrant Agreements [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants																													$ 437,031
Private Placement [Member] | Black Sholes Method [Member]
Subsidiary, Sale of Stock [Line Items]
Fair value assumptions, contractual term																					5 years 6 months
Risk free interest rate																			4.70%		4.20%
Volatility rate																			95.00%		95.00%
Warrants																			$ 677,919		$ 2,049,600
Private Placement [Member] | Black Sholes Method [Member] | Director [Member]
Subsidiary, Sale of Stock [Line Items]
Fair value assumptions, contractual term														6 years	6 years	5 years 6 months	5 years 6 months		5 years 6 months		5 years 6 months
Risk free interest rate														3.97%	4.23%	4.25%	4.22%		4.70%		4.20%
Volatility rate														95.00%	95.00%	95.00%	95.00%		95.00%		95.00%
Fair value of warrant														$ 1,240,185	$ 2,416,223	$ 635,345	$ 1,800,389
Warrants														$ 80,894	$ 176,680	$ 116,151	$ 494,851		$ 346,606		$ 230,685										$ 176,680
Private Placement [Member] | Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Number of common stock sold	1,233,488				603,769	1,733,766				463,332	719,999			952,633	1,810,000	507,364	1,079,784		494,096	578,643	2,496,318
Private Placement [Member] | Investor Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of common stock sold	1,233,488				603,769	1,733,766				463,332	719,999			952,633	1,810,000	507,364	1,079,784		494,096	578,643	2,496,318
Sale of common stock, price per share	$ 1.36				$ 1.52	$ 1.57				$ 1.71	$ 2.05			$ 1.85	$ 1.87	$ 2.08	$ 2.51		$ 2.26	$ 2.55	$ 1.30										$ 1.87
Private Placement Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Number of common stock sold		80,127			11,475								108,931																	12,291
Sale of common stock, price per share					$ 1.52
Warrants and rights expiration date	Dec. 22, 2028		Nov. 05, 2028		Oct. 16, 2028	Oct. 01, 2028				Jun. 03, 2030	May 08, 2031			Mar. 03, 2031	Feb. 24, 2031	Jun. 13, 2030	May 01, 2030		Oct. 25, 2029	Sep. 28, 2029											Feb. 24, 2031
Warrants to purchase aggregate of common stock																													437,031
Warrants and rights exercisable period	Jun. 22, 2026		May 05, 2026		Apr. 16, 2026	Apr. 01, 2026				Dec. 03, 2025	May 08, 2026			Mar. 03, 2026		Jun. 13, 2025	May 01, 2025		Oct. 25, 2024	Sep. 28, 2024											Feb. 24, 2026
Fair value of warrant																														$ 0		112,708
Class of warrants exercised		80,127											108,931																	12,291
Private Placement Offering [Member] | Amendment Of Warrant Agreements [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants																													$ 1,011,562
Private Placement Offering [Member] | Investors [Member]
Subsidiary, Sale of Stock [Line Items]
Number of common stock sold																														379,970
Class of warrants exercised																														379,970
Private Placement Offering [Member] | Black Sholes Method [Member]
Subsidiary, Sale of Stock [Line Items]
Fair value assumptions, contractual term					3 years														5 years 6 months	5 years 6 months
Risk free interest rate					3.65%															4.20%
Volatility rate					90.00%									95.00%	95.00%	95.00%	95.00%			95.00%
Warrants					$ 6,518															$ 1,190,111
Private Placement Offering [Member] | Black Sholes Method [Member] | Director [Member]
Subsidiary, Sale of Stock [Line Items]
Fair value assumptions, contractual term	3 years					3 years				5 years	6 years
Risk free interest rate	3.56%					3.56%				4.04%	4.09%
Volatility rate	90.00%					90.00%				95.00%	95.00%
Warrants	$ 138,784					$ 18,818				$ 43,358	$ 133,131
Private Placement Offering [Member] | Common Stock [Member] | Director [Member] | 2021 Equity Incentive Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Number of common stock sold		428,946		846,984								167,157		58,333	123,333	78,418	232,800				452,731
Private Placement Offering [Member] | Common Stock [Member] | Non Affiliated Investors [Member]
Subsidiary, Sale of Stock [Line Items]
Number of common stock sold	1,053,751				603,769	1,714,536				429,999	633,333								326,939		2,043,587
Private Placement Offering [Member] | Common Stock [Member] | Affiliated And Nonaffiliated Investor [Member] | 2021 Equity Incentive Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Number of common stock sold														894,300	1,686,667
Private Placement Offering [Member] | Investor Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of common stock sold	1,233,488					1,733,766				463,332	719,999			952,633	1,810,000	507,364	1,079,784		494,096	578,643
Sale of common stock, price per share	$ 1.36				$ 1.52	$ 1.57				$ 1.71	$ 1.50			$ 1.85	$ 1.87	$ 2.08	$ 2.51		$ 2.26	$ 2.55											$ 1.87
Private Placement Offering [Member] | Outside Investors Warrants [Member] | Black Sholes Method [Member]
Subsidiary, Sale of Stock [Line Items]
Fair value assumptions, contractual term	3 years				3 years	3 years				5 years	6 years
Risk free interest rate	3.56%				3.42%	3.56%				4.04%	4.09%
Volatility rate	90.00%				90.00%	90.00%				95.00%	95.00%
Warrants	$ 813,657				$ 475,967	$ 1,677,758				$ 559,324	$ 972,890
Private Placement Offering [Member] | Maximum [Member] | Investor Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of common stock sold					603,769
Over-Allotment Option [Member] | Maximum [Member]
Subsidiary, Sale of Stock [Line Items]
Class of warrant or right additional purchase aggregate of common stock																											15,000
IPO [Member] | Black Sholes Method [Member]
Subsidiary, Sale of Stock [Line Items]
Warrant liability																														$ 27,455		71,672
Fair value of warrant																														$ 44,217		$ 31,461
Follow On Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Number of common stock sold																																22,869
Class of warrants exercised																														0		116,532
warrants exercisable																														11,243
Registered Direct Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants and rights expiration date																							Nov. 15, 2028
Warrants to purchase aggregate of common stock																							169,697
Warrant exercise price per share																						$ 1.86	$ 2.06
Warrants and rights exercisable period																							Nov. 15, 2023
Fair value assumptions, contractual term																						5 years 4 months 17 days	4 years 10 months 17 days
Risk free interest rate																						3.85%	3.84%
Volatility rate																						90.00%	90.00%
Fair value of warrant																														$ 99,485		$ 106,227
Warrants																						$ 1,903,915	$ 123,811							130,553		$ 230,038
Registered Direct Offering [Member] | Black Sholes Method [Member]
Subsidiary, Sale of Stock [Line Items]
Number of common stock sold																																909,091
Fair value of warrant																														972,704		$ 3,101,533
Warrants																														1,216,774		2,189,478
Registered Direct Offering [Member] | Maximum [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase aggregate of common stock																						2,424,243
Private Placement Offering One [Member]
Subsidiary, Sale of Stock [Line Items]
Fair value of warrant																														0		91,752
Private Placement Offering One [Member] | Amendment Of Warrant Agreements [Member]
Subsidiary, Sale of Stock [Line Items]
Fair value of warrant																														81,804		91,840
Warrants																														$ 117,613		199,417
Remaining warrant liability																														141,612
H C Wainwright And Co LLC [Member] | At The Market Offering Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Number of common stock sold																														3,782,335
Sale of common stock, price per share																														$ 1.90
Proceeds from sale of common stock																														$ 7,202,016
Commissions paid																														216,060
Other financing expenses																														111,555
Net proceeds from common stock																														6,874,401
H C Wainwright And Co LLC [Member] | At The Market Offering Agreement [Member] | Maximum [Member] | Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Aggregate offering price																																		$ 11,200,000	$ 30,000,000	$ 11,280,000	$ 4,950,000	$ 1,445,000
Laidlaw And Company Ltd [Member] | Alumni Capital Lp [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants and rights exercisable period																									May 22, 2024
Fair value of warrant																														$ 0		$ 291,454
Warrants																									$ 375,705
Class of warrants exercised																						909,091		54,976
Warrant fee paid in cash																									$ 13,750